Posted 23 May 2010 - 02:40 PM
An Indian company, Sun Pharmaceuticals, was granted U.S. permission to sell generic Imatinib.
Ant the site below indicates one can buy Imatinib for a fraction of what Novartis' Gleevec costs.
http://www.genericsm...late-p-723.html
Anyone know the 'real' story. Gleevec is under patent protection for a long time to come.
?
Diagnosed 11 May 2011 (100% FiSH, 155% PCR)
with b2a2 BCR-ABL fusion transcript coding for the 210kDa BCR-ABL protein
Sprycel: 20 mg per day - taken at lights out with Quercetin and/or Magnesium Taurate
6-8 grams Curcumin C3 complex.
2015 PCR: < 0.01% (M.D. Anderson scale)
2016 PCR: < 0.01% (M.D. Anderson scale)
March 2017 PCR: 0.01% (M.D. Anderson scale)
June 2017 PCR: "undetected"
September 2017 PCR: "undetected"